타다라필(Tadalafil) 시장 규모는 향후 수년간 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 12.46% 성장하여 88억 7,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 예상되는 성장 동력은 발기부전 유병률 증가, 생활습관병 치료제에 대한 수요 증가, 폐동맥 고혈압(PAH) 사례 증가, 최신 의료 솔루션의 채택 확대, 가처분 소득 증가입니다. 이 기간 중 예상되는 주요 동향으로는 디지털 건강의 통합, 혁신적인 약물 처방, 의약품의 발전, 약물전달 시스템의 개선, 의료 기술의 발전 등이 있습니다.
발기부전 유병률 증가는 향후 수년간 타다라필 시장의 성장을 촉진할 것으로 예측됩니다. 발기부전(ED)은 만족스러운 성행위를 하기에 충분한 발기가 지속되지 않거나 유지되지 않는 것을 특징으로 하는 질환으로, 인구 고령화, 만성 건강 상태, 건강에 해로운 생활습관, 심리적 스트레스, 특정 약물의 부작용 등이 발기부전 유병률 증가의 요인으로 작용하고 있습니다. 타다라필은 음경 혈관의 평활근을 이완시키고, 혈류를 개선하고, 성적 자극시 발기를 가능하게 함으로써 발기부전을 치료합니다. 예를 들어 국립의학도서관의 2024년 2월 보고에 따르면 IIEF-5 점수로 측정한 ED 유병률은 일반 인구에서 24.2%이며, 65세 이상에서는 65-74세에서 48.0%, 75세 이상에서 52.2%로 현저하게 높은 것으로 나타났습니다. 이러한 유병률 증가는 타다라필 시장 확대에 박차를 가하고 있습니다.
타다라필 시장의 주요 업체들은 발기부전 및 폐동맥 고혈압 관리에서 치료 효과를 높이고 환자 순응도를 높이며 시장 입지를 강화하기 위해 병용요법과 같은 혁신적인 제제를 우선시하고 있습니다. 병용요법은 두 가지 이상의 약물을 동시에 사용하여 치료 결과를 개선하고, 병의 여러 측면을 다루며, 치료 효과를 높이기 위해 두 가지 이상의 약물을 동시에 사용하는 것을 말합니다. 예를 들어 2024년 3월 존슨앤드존슨은 엔도세린 수용체 길항제(ERA) 마키텐탄과 포스포디에스터라아제5(PDE5) 억제제 타다라필을 결합한 단일정제 요법인 OPSYNVI에 대한 FDA 승인을 발표했습니다. OPSYNVI는 WHO 기능 분류 II-III 등급의 성인 폐동맥 고혈압(PAH)의 만성 관리를 위해 설계되었으며, 치료 경험이 없거나 ERA, PDE5 억제제 또는 둘 다로 이미 안정된 환자들에게도 적합합니다. 이 혁신적인 치료법은 기존에 맥시텐탄과 타다라필을 따로 복용하던 환자들의 치료 요법을 간소화할 수 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 타다라필 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 타다라필 시장 : 성장률 분석
- 세계의 타다라필 시장 실적 : 규모와 성장, 2019-2024
- 세계의 타다라필 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 타다라필 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 타다라필 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 정제
- 경구 현탁액
- 세계의 타다라필 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 타다라필 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 발기부전
- 폐동맥 고혈압
- 양성 전립선 비대증
- 세계의 타다라필 시장, 정제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 2.5mg 정제
- 5mg 정제
- 10mg 정제
- 20mg 정제
- 세계의 타다라필 시장, 경구 현탁액의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 2.5mg/5mL 경구 현탁액
- 10mg/5mL 경구 현탁액
- 커스텀 투여 경구 현탁액
제7장 지역별·국가별 분석
- 세계의 타다라필 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 타다라필 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 타다라필 시장 : 경쟁 구도
- 타다라필 시장 : 기업 개요
- Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
- Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Dr. Reddy's Laboratories Limited
- Lupin Limited
- Glenmark Pharmaceuticals Limited
- Torrent Pharmaceuticals Limited
- Jubilant Pharma Limited
- Jiangsu Lianhuan Pharmaceutical Co. Ltd.
- Alembic Pharmaceuticals Limited
- Polpharma SA
- SMS Pharmaceuticals Limited
- Camber Pharmaceuticals Inc.
- Century Pharmaceuticals Limited
- Rakshit Drugs Private Limited
- Ami Lifesciences Private Limited
- Hangzhou Longshine Bio-Tech Co. Ltd.
- Dolphin Pharmaceuticals
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 타다라필 시장 2029 : 새로운 기회를 제공하는 국가
- 타다라필 시장 2029 : 새로운 기회를 제공하는 부문
- 타다라필 시장 2029 : 성장 전략
제36장 부록
KSA
Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor primarily used to treat erectile dysfunction and pulmonary arterial hypertension. It functions by relaxing blood vessels, enhancing blood flow to specific areas, and effectively managing these conditions.
Tadalafil is available mainly in two forms, tablets and oral suspensions. Tadalafil tablets, being solid oral medications, offer accurate dosing, are user-friendly, and are widely prescribed for erectile dysfunction due to their effectiveness and ease of use. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies. It is utilized for various purposes, including the treatment of erectile dysfunction, pulmonary arterial hypertension, and benign prostatic hyperplasia.
The tadalafil market research report is one of a series of new reports from The Business Research Company that provides tadalafil market statistics, including the tadalafil industry global market size, regional shares, competitors with the tadalafil market share, detailed tadalafil market segments, market trends, and opportunities, and any further data you may need to thrive in the tadalafil industry. This tadalafil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The tadalafil market size has grown rapidly in recent years. It will grow from $4.92 billion in 2024 to $5.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.83%. The growth during the historical period can be attributed to increasing awareness of men's health, the rising usage of medications, the expanding tadalafil market, growing healthcare expenditures, and an aging population.
The tadalafil market size is expected to see rapid growth in the next few years. It will grow to $8.87 billion in 2029 at a compound annual growth rate (CAGR) of 12.46%. The anticipated growth in the forecast period is driven by a higher prevalence of erectile dysfunction, a growing demand for lifestyle medications, an increase in pulmonary arterial hypertension (PAH) cases, greater adoption of modern healthcare solutions, and rising disposable incomes. Key trends expected during this period include the integration of digital health, innovative drug formulations, advancements in pharmaceuticals, improved drug delivery systems, and progress in medical technology.
The rising prevalence of erectile dysfunction is expected to drive the growth of the tadalafil market in the coming years. Erectile dysfunction (ED) is a condition characterized by the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. Factors contributing to the increasing prevalence of ED include an aging population, chronic health conditions, unhealthy lifestyle choices, psychological stress, and the side effects of certain medications. Tadalafil addresses ED by relaxing smooth muscles in the blood vessels of the penis, improving blood flow, and enabling an erection during sexual stimulation. For example, a February 2024 report from the National Library of Medicine revealed that the prevalence of ED, as measured by IIEF-5 scores, is 24.2% in the general population, with significantly higher rates among individuals aged 65 and older, affecting 48.0% of those aged 65-74 and 52.2% of those 75 and older. This growing prevalence is fueling the expansion of the tadalafil market.
Leading companies in the tadalafil market are prioritizing innovative formulations, such as combination therapies, to boost treatment efficacy, enhance patient compliance, and strengthen their market presence in managing erectile dysfunction and pulmonary arterial hypertension. Combination therapy involves the simultaneous use of two or more medications to improve therapeutic outcomes, address multiple aspects of a condition, and enhance treatment effectiveness. For instance, in March 2024, Johnson & Johnson announced FDA approval for OPSYNVI, a single-tablet therapy combining macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. Designed for the chronic management of pulmonary arterial hypertension (PAH) in adults with WHO functional class II-III, OPSYNVI is suitable for both treatment-naive patients and those already stabilized on ERA, PDE5 inhibitors, or both. This innovative therapy simplifies treatment regimens for patients previously taking macitentan and tadalafil separately.
In February 2024, Zuellig Pharma Holdings Ltd., a Singapore-based healthcare solutions provider, acquired Cialis (Tadalafil) and Alimta (Pemetrexed) from Eli Lilly and Company for an undisclosed sum. The acquisition allows Zuellig Pharma to expand its pharmaceutical portfolio, strengthen its market presence, and meet the growing demand for treatments addressing erectile dysfunction (Cialis) and cancer (Alimta) within its operational regions. Eli Lilly and Company, a US-based pharmaceutical firm, produces tadalafil-based treatments for erectile dysfunction and pulmonary arterial hypertension.
Major players in the tadalafil market are Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Jubilant Pharma Limited, Jiangsu Lianhuan Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Polpharma SA, SMS Pharmaceuticals Limited, Camber Pharmaceuticals Inc., Century Pharmaceuticals Limited, Rakshit Drugs Private Limited, Ami Lifesciences Private Limited, Hangzhou Longshine Bio-Tech Co. Ltd., Dolphin Pharmaceuticals.
North America was the largest region in the tadalafil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tadalafil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tadalafil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tadalafil market consists of sales of injectable formulations, extended-release formulations, and topical formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tadalafil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tadalafil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tadalafil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tadalafil market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Tablets; Oral Suspensions
- 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
- 3) By Application: Erectile Dysfunction; Pulmonary Arterial Hypertension; Benign Prostatic Hyperplasia
- Subsegments:
- 1) By Tablets: 2.5 mg Tablets; 5 mg Tablets; 10 mg Tablets; 20 mg Tablets
- 2) By Oral Suspensions: 2.5 mg/5 mL Oral Suspension; 10 mg/5 mL Oral Suspension; Custom Dosing Oral Suspensions
- Companies Mentioned: Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Limited; Cipla Limited; Aurobindo Pharma Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Tadalafil Market Characteristics
3. Tadalafil Market Trends And Strategies
4. Tadalafil Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Tadalafil Growth Analysis And Strategic Analysis Framework
- 5.1. Global Tadalafil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Tadalafil Market Growth Rate Analysis
- 5.4. Global Tadalafil Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Tadalafil Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Tadalafil Total Addressable Market (TAM)
6. Tadalafil Market Segmentation
- 6.1. Global Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Oral Suspensions
- 6.2. Global Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- 6.3. Global Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Erectile Dysfunction
- Pulmonary Arterial Hypertension
- Benign Prostatic Hyperplasia
- 6.4. Global Tadalafil Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 2.5 mg Tablets
- 5 mg Tablets
- 10 mg Tablets
- 20 mg Tablets
- 6.5. Global Tadalafil Market, Sub-Segmentation Of Oral Suspensions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 2.5 mg/5 mL Oral Suspension
- 10 mg/5 mL Oral Suspension
- Custom Dosing Oral Suspensions
7. Tadalafil Market Regional And Country Analysis
- 7.1. Global Tadalafil Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Tadalafil Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tadalafil Market
- 8.1. Asia-Pacific Tadalafil Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tadalafil Market
- 9.1. China Tadalafil Market Overview
- 9.2. China Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tadalafil Market
- 10.1. India Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tadalafil Market
- 11.1. Japan Tadalafil Market Overview
- 11.2. Japan Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tadalafil Market
- 12.1. Australia Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tadalafil Market
- 13.1. Indonesia Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tadalafil Market
- 14.1. South Korea Tadalafil Market Overview
- 14.2. South Korea Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tadalafil Market
- 15.1. Western Europe Tadalafil Market Overview
- 15.2. Western Europe Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tadalafil Market
- 16.1. UK Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tadalafil Market
- 17.1. Germany Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tadalafil Market
- 18.1. France Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tadalafil Market
- 19.1. Italy Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tadalafil Market
- 20.1. Spain Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tadalafil Market
- 21.1. Eastern Europe Tadalafil Market Overview
- 21.2. Eastern Europe Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tadalafil Market
- 22.1. Russia Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tadalafil Market
- 23.1. North America Tadalafil Market Overview
- 23.2. North America Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tadalafil Market
- 24.1. USA Tadalafil Market Overview
- 24.2. USA Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tadalafil Market
- 25.1. Canada Tadalafil Market Overview
- 25.2. Canada Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tadalafil Market
- 26.1. South America Tadalafil Market Overview
- 26.2. South America Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tadalafil Market
- 27.1. Brazil Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tadalafil Market
- 28.1. Middle East Tadalafil Market Overview
- 28.2. Middle East Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tadalafil Market
- 29.1. Africa Tadalafil Market Overview
- 29.2. Africa Tadalafil Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Tadalafil Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Tadalafil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tadalafil Market Competitive Landscape And Company Profiles
- 30.1. Tadalafil Market Competitive Landscape
- 30.2. Tadalafil Market Company Profiles
- 30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
31. Tadalafil Market Other Major And Innovative Companies
- 31.1. Dr. Reddy's Laboratories Limited
- 31.2. Lupin Limited
- 31.3. Glenmark Pharmaceuticals Limited
- 31.4. Torrent Pharmaceuticals Limited
- 31.5. Jubilant Pharma Limited
- 31.6. Jiangsu Lianhuan Pharmaceutical Co. Ltd.
- 31.7. Alembic Pharmaceuticals Limited
- 31.8. Polpharma SA
- 31.9. SMS Pharmaceuticals Limited
- 31.10. Camber Pharmaceuticals Inc.
- 31.11. Century Pharmaceuticals Limited
- 31.12. Rakshit Drugs Private Limited
- 31.13. Ami Lifesciences Private Limited
- 31.14. Hangzhou Longshine Bio-Tech Co. Ltd.
- 31.15. Dolphin Pharmaceuticals
32. Global Tadalafil Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tadalafil Market
34. Recent Developments In The Tadalafil Market
35. Tadalafil Market High Potential Countries, Segments and Strategies
- 35.1 Tadalafil Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Tadalafil Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Tadalafil Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
